419 related articles for article (PubMed ID: 36946241)
1. Health-related quality of life among transthyretin amyloid cardiomyopathy patients.
Eldhagen P; Lehtonen J; Gude E; Gustafsson F; Bagger-Bahnsen A; Vakevainen M; Pilgaard T; Wedell-Wedellsborg D; Poulsen SH;
ESC Heart Fail; 2023 Jun; 10(3):1871-1882. PubMed ID: 36946241
[TBL] [Abstract][Full Text] [Related]
2. Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial.
Xie J; Wang Y; Xu Y; Fine JT; Lam J; Garrison LP
J Med Econ; 2022; 25(1):51-58. PubMed ID: 34907813
[TBL] [Abstract][Full Text] [Related]
3. Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT.
Nativi-Nicolau J; Judge DP; Hoffman JE; Gundapaneni B; Keohane D; Sultan MB; Grogan M
ESC Heart Fail; 2021 Oct; 8(5):3875-3884. PubMed ID: 34432383
[TBL] [Abstract][Full Text] [Related]
4. What to expect after open heart valve surgery? Changes in health-related quality of life.
Borregaard B; Pedersen SS; Berg SK; Dahl J; Ekholm O; Sibilitz K; Zwisler ADO; Lauck SB; Kyte D; Calvert M; Riber LPS; Møller JE
Qual Life Res; 2020 May; 29(5):1247-1258. PubMed ID: 31875308
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
[TBL] [Abstract][Full Text] [Related]
6. Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).
Hanna M; Damy T; Grogan M; Stewart M; Gundapaneni B; Patterson TA; Schwartz JH; Sultan MB; Maurer MS
Am J Cardiol; 2021 Feb; 141():98-105. PubMed ID: 33220323
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
Rapezzi C; Elliott P; Damy T; Nativi-Nicolau J; Berk JL; Velazquez EJ; Boman K; Gundapaneni B; Patterson TA; Schwartz JH; Sultan MB; Maurer MS
JACC Heart Fail; 2021 Feb; 9(2):115-123. PubMed ID: 33309574
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire.
Ravera A; Santema BT; Sama IE; Meyer S; Lombardi CM; Carubelli V; Ferreira JP; Lang CC; Dickstein K; Anker SD; Samani NJ; Zannad F; van Veldhuisen DJ; Teerlink JR; Metra M; Voors AA
Eur J Heart Fail; 2021 Apr; 23(4):567-577. PubMed ID: 33728762
[TBL] [Abstract][Full Text] [Related]
9. Limited health literacy results in lower health-related quality of life in spine patients.
Koole D; Lans A; Lang JH; de Groot TM; Borkhetaria P; Verlaan JJ; Schwab JH; Tobert DG
Spine J; 2024 Feb; 24(2):263-272. PubMed ID: 37774984
[TBL] [Abstract][Full Text] [Related]
10. Examining health-related quality of life in ambulatory adult patients with chronic heart failure: insights from Malaysia using EQ-5D-5L.
Tan YJ; Ong SC; Yong VS; Khor WW; Pang LJ; Choong YY; Zameram AM; Tan LY; Voo JYH; Lam KK; Yen CH; Wahab MJA; Abdulla ZB
Qual Life Res; 2024 Jun; ():. PubMed ID: 38839679
[TBL] [Abstract][Full Text] [Related]
11. Health care resource use, diagnostic delay and disease burden in transthyretin amyloid cardiomyopathy in Sweden.
Hjalte F; Norlin JM; Alverbäck-Labberton L; Johansson K; Wikström G; Eldhagen P
Ann Med; 2023; 55(2):2292686. PubMed ID: 38096896
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries.
Lauppe R; Liseth Hansen J; Fornwall A; Johansson K; Rozenbaum MH; Strand AM; Väkeväinen M; Kuusisto J; Gude E; Smith JG; Gustafsson F
ESC Heart Fail; 2022 Aug; 9(4):2528-2537. PubMed ID: 35560802
[TBL] [Abstract][Full Text] [Related]
13. Association of Tafamidis With Health Status in Patients With ATTR Cardiac Amyloidosis: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial.
Sperry BW; Hanna M; Maurer MS; Nativi-Nicolau J; Floden L; Stewart M; Wyrwich KW; Barsdorf AI; Kapadia H; Spertus JA
JAMA Cardiol; 2023 Mar; 8(3):275-280. PubMed ID: 36723935
[TBL] [Abstract][Full Text] [Related]
14. Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey.
Hołownia-Voloskova M; Tarbastaev A; Golicki D
Qual Life Res; 2021 Mar; 30(3):831-840. PubMed ID: 33237551
[TBL] [Abstract][Full Text] [Related]
15. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life among Indian population: The EQ-5D population norms for India.
Jyani G; Prinja S; Garg B; Kaur M; Grover S; Sharma A; Goyal A
J Glob Health; 2023 Feb; 13():04018. PubMed ID: 36799239
[TBL] [Abstract][Full Text] [Related]
17. Association between in-hospital frailty and health-related quality of life after stroke: the Nor-COAST study.
Wæhler IS; Saltvedt I; Lydersen S; Fure B; Askim T; Einstad MS; Thingstad P
BMC Neurol; 2021 Mar; 21(1):100. PubMed ID: 33663430
[TBL] [Abstract][Full Text] [Related]
18. Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis.
Aimo A; Rapezzi C; Perfetto F; Cappelli F; Palladini G; Obici L; Merlini G; Di Bella G; Serenelli M; Zampieri M; Milani P; Licordari R; Teresi L; Ribarich N; Castiglione V; Quattrone F; De Rosis S; Vergaro G; Panichella G; Emdin M; Passino C
Eur J Clin Invest; 2021 Nov; 51(11):e13598. PubMed ID: 33982288
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
[TBL] [Abstract][Full Text] [Related]
20. Inequality and heterogeneity in health-related quality of life: findings based on a large sample of cross-sectional EQ-5D-5L data from the Swedish general population.
Teni FS; Gerdtham UG; Leidl R; Henriksson M; Åström M; Sun S; Burström K
Qual Life Res; 2022 Mar; 31(3):697-712. PubMed ID: 34628587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
